Exchange: NASDAQ Capital Market Sector: Financial Services Industry: Shell Companies
43.64% $16.59
/ 29 nov 2023 @ 15:57
FUNDAMENTALS | |
---|---|
MarketCap: | 119.82 mill |
EPS: | 0.111 |
P/E: | 149.46 |
Earnings Date: | Mar 30, 2023 |
SharesOutstanding: | 7.22 mill |
Avg Daily Volume: | 0.0027 mill |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
2/22 | 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Gr.Profit | n/a | n/a | n/a | n/a | n/a | n/a |
Ebit | ||||||
Asset | ||||||
Debt |
PE RATIO: COMPANY / SECTOR |
---|
0.00x |
Company: PE 149.46 | sector: PE 0 |
PE RATIO: COMPANY / INDUSTRY |
---|
0x |
Company: PE 149.46 | industry: PE 0 |
DISCOUNTED CASH FLOW VALUE |
---|
N/A |
N/A |
Expected Trading Range (DAY) |
---|
$ 15.67 - 17.51 ( +/- 5.56%) |
ATR Model: 14 days |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-12-14 | Cfac Holdings Viii, Llc. | Sell | 23 159 | Common stock |
2023-12-14 | Cfac Holdings Viii, Llc. | Sell | 40 847 | Common stock |
2023-12-14 | Cfac Holdings Viii, Llc. | Sell | 36 670 | Common stock |
2023-11-29 | Exela Technologies, Inc. | Buy | 0 | Common Stock |
2023-11-29 | Akins Martin P. | Buy | 0 |
INSIDER POWER |
---|
1.40 |
Last 19 transactions |
Buy: 3 577 080 | Sell: 9 350 676 |
Indicator Signals | |
---|---|
RSI 21 | |
SMA | |
Trend | |
Trend 2 | |
Trend 3 | |
MACD |
Volume Signals | |
---|---|
Price | $16.59 (43.64% ) |
Volume | 0.0134 mill |
Avg. Vol. | 0.0027 mill |
% of Avg. Vol | 499.07 % |
Signal 1: | |
Signal 2: |
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Date | Signal | @ | Closed | % |
---|
CF Acquisition Corp. VIII does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.